Live feed08:03:00·662dPRReleasevia QuantisnowCitius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to ApprovalByQuantisnow·Wall Street's wire, on your screen.CTXR· Citius Pharmaceuticals Inc.Health Care
